Get the app!
Back to Trades

KIRSKE DAVID

Chief Financial OfficerCIK 0001276750

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
5
Buy transactions
0
Sell transactions
2
Companies
1
Active
2025–2026

Across 5 filings between 2025–2026, KIRSKE DAVID, Chief Financial Officer, has disclosed $4.9M in transactions — all concentrated in X4 Pharmaceuticals, Inc (XFOR). Their disclosed trades are heavily weighted toward selling — $0 in buys and $70.1K in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

5 loaded
Oct 5XFOR
X4 Pharmaceuticals, Inc
KIRSKE DAVIDChief Financial OfficerSell$33.7K
Jul 1XFOR
X4 Pharmaceuticals, Inc
KIRSKE DAVIDChief Financial OfficerSell$36.4K
Oct 31XFOR
X4 Pharmaceuticals, Inc
KIRSKE DAVIDChief Financial OfficerAward$2.2M
Aug 14XFOR
X4 Pharmaceuticals, Inc
KIRSKE DAVIDChief Financial OfficerGrant$2.6M
Aug 14XFOR
X4 Pharmaceuticals, Inc
KIRSKE DAVIDChief Financial OfficerOther$0

5 filings